Epidiolex 100 MG/ML soln pack 100ML
Ended Awarded
- Contract number
- SPE2DB25FY9QC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,413
Award facts
- Contract value 100% obligated
- $8,412.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $8,412.50 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Epidiolex 100 mg/ml solution in 100 ml packs, with completion targeted for September 10, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Epidiolex is an FDA-approved cannabidiol-based medication indicated for the treatment of certain types of seizures. This delivery order supports DLA's medical supply chain operations, providing specialized pharmaceutical products to military and veteran healthcare systems. AmerisourceBergen's contract portfolio with DLA demonstrates the company's established capability to deliver a broad spectrum of pharmaceuticals and medical supplies competitively, ranging from routine medications to specialty therapeutics across multiple therapeutic domains. The SPE2DX master contract reflects AmerisourceBergen's role as a critical pharmaceutical distributor within the federal medical procurement system, with capacity to support Defense Health Agency, U.S. Coast Guard, and other government healthcare entities worldwide.
Quick answers
Who was awarded contract SPE2DB25FY9QC?
SPE2DB25FY9QC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 19, 2025.
How much is contract SPE2DB25FY9QC worth?
The government has obligated $8,413 on SPE2DB25FY9QC.
Is contract SPE2DB25FY9QC an order under another contract?
Yes. SPE2DB25FY9QC is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY9QC competed?
The extent of competition for SPE2DB25FY9QC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award